Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-04-1513PMID 16249391PMCID PMC1895708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

  2005cited by this paper
• HLA-B63 Presents HLA-B57/B58-Restricted Cytotoxic T-Lymphocyte Epitopes and Is Associated with Low Human Immunodeficiency Virus Load

  2005cited by this paper
• A cytosolic pathway for MHC class II–restricted antigen processing that is proteasome and TAP dependent

  2005cited by this paper
• CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides

  2005cited by this paper
• Generation of autologous peptide- and protein-pulsed dendritic cells for patient-specific immunotherapy.

  2005cited by this paper
• DNA vaccine encoding human immunodeficiency virus‐1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal‐associated membrane protein, elicits enhanced long‐term memory response

  2004cited by this paper
• Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

  2004cited by this paper
• Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities

  2004cited by this paper
• Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T Cells

  2004cited by this paper
• Cancer immunotherapy with mRNA‐transfected dendritic cells

  2004cited by this paper
• The Effects of HIV-1 Nef on CD4 Surface Expression and Viral Infectivity in Lymphoid Cells Are Independent of Rafts*

  2004cited by this paper
• Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

  2003cited by this paper
• Advantage of rare HLA supertype in HIV disease progression

  2003cited by this paper
• Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection

  2003cited by this paper
• Therapeutic dendritic-cell vaccine for simian AIDS

  2003cited by this paper
• HIV-1 p55Gag Encoded in the Lysosome-associated Membrane Protein-1 as a DNA Plasmid Vaccine Chimera Is Highly Expressed, Traffics to the Major Histocompatibility Class II Compartment, and Elicits Enhanced Immune Responses*

  2003cited by this paper
• Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy

  2003cited by this paper
• Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.

  2003cited by this paper
• Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

  2002cited by this paper
• Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.

  2002cited by this paper
• HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

  2002cited by this paper
• Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation

  2002cited by this paper
• Emerging clinical applications of RNA

  2002cited by this paper
• A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.

  2002cited by this paper
• Targeting Antigen in Mature Dendritic Cells for Simultaneous Stimulation of CD4+ and CD8+ T Cells1

  2001cited by this paper
• HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response1

  2000cited by this paper
• Targeting of Hepatitis C Virus Core Protein for MHC I or MHC II Presentation Does Not Enhance Induction of Immune Responses to DNA Vaccination

  1999cited by this paper
• Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.

  1999cited by this paper
• New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.

  1999cited by this paper
• Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

  1998cited by this paper
• Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

  1996cited by this paper
• Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

  1995cited by this paper
• Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells.

  1995cited by this paper
• The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.

  1992cited by this paper

• Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates.

  2025cites this paper
• mRNA vaccines against HIV: Hopes and challenges

  2025cites this paper
• Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

  2024cites this paper
• Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies

  2021cites this paper
• Recent developments of RNA-based vaccines in cancer immunotherapy

  2020cites this paper
• Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

  2020cites this paper
• Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism

  2020cites this paper
• Weighted lambda superstrings applied to vaccine design

  2019cites this paper
• Immunotherapy with mRNA vaccination and immunomodulation nanomedicine for cancer therapy

  2019cites this paper
• Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individuals.

  2018cites this paper
• Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection

  2016cites this paper
• Impact de l’infection par le virus de l’immunodéficience humaine sur les populations de lymphocytes T folliculaires helper et les réponses B mémoires

  2016cites this paper
• Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial

  2016cites this paper
• HIV-Infected Dendritic Cells Present Endogenous MHC Class II–Restricted Antigens to HIV-Specific CD4+ T Cells

  2016cites this paper
• Gr upSM Antitumor Gene Immunotherapy in Melanoma

  2016cites this paper
• RNA-Based Vaccines in Cancer Immunotherapy

  2015cites this paper
• Interleukin-12 p 70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulate gag-Specific Immune Responses

  2014cites this paper
• Reprogramming to pluripotency and differentiation of cells with synthetic mRNA.

  2013cites this paper
• Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses.

  2013cites this paper
• Aminopeptidase Substrate Preference Affects HIV Epitope Presentation and Predicts Immune Escape Patterns in HIV-Infected Individuals

  2012cites this paper
• Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System

  2012cites this paper
• Interleukin-12p70 Expression by Dendritic Cells of HIV-1-Infected Patients Fails to Stimulate gag-Specific Immune Responses

  2012influential citation
• HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.

  2012cites this paper
• “Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy

  2012cites this paper
• IndividualsImmune Escape Patterns in HIV-Infected HIV Epitope Presentation and Predicts Aminopeptidase Substrate Preference Affects

  2012cites this paper
• Advances in dendritic cell-based vaccines for HIV.

  2011cites this paper
• In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.

  2011cites this paper
• Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.

  2011cites this paper
• Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.

  2011cites this paper
• In vitro and in vivo mRNA delivery using lipid-enveloped pHresponsive polymer nanoparticles

  2011cites this paper
• Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1

  2010cites this paper
• Lumenal Part of the DC-LAMP Protein Is Not Required for Induction of Antigen-Specific T Cell Responses by Means of Antigen-DC-LAMP Messenger RNA-Electroporated Dendritic Cells

  2010cites this paper
• Role of dendritic cells in HIV-immunotherapy.

  2010cites this paper
• Soluble HLA-G Inhibits Myeloid Dendritic Cell Function in HIV-1 Infection by Interacting with Leukocyte Immunoglobulin-Like Receptor B2

  2010cites this paper
• Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.

  2010cites this paper
• Leukocyte Immunoglobulin-Like Receptors Maintain Unique Antigen-Presenting Properties of Circulating Myeloid Dendritic Cells in HIV-1-Infected Elite Controllers

  2010cites this paper
• Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.

  2010cites this paper
• A phagocytotic inducer from herbal constituent, pentagalloylglucose enhances lipoplex-mediated gene transfection in dendritic cells.

  2010cites this paper
• Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients

  2009cites this paper
• Novel strategies for improved cancer vaccines

  2009cites this paper
• A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

  2009cites this paper
• HLA-B*35-Px–mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses

  2009influential citation
• Dendritic cell immunotherapy for HIV infection: from theory to reality.

  2009cites this paper
• Immunotherapy of viral infections.

  2009cites this paper
• Dendritic cell‐based human immunodeficiency virus vaccine

  2009cites this paper
• Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

  2008cites this paper
• Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells

  2008cites this paper
• High-Level Antigen Expression and Sustained Antigen Presentation in Dendritic Cells Nucleofected with Wild-Type Viral mRNA but Not DNA

  2008influential citation
• Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.

  2008cites this paper
• DENDRITIC CELLS TRANSFECTED WITH AUTOLOGOUS SIV RNA: POTENTIAL AIDS VACCINE

  2008cites this paper
• Efficient In Vitro Expansion of Human Immunodeficiency Virus (HIV)-Specific T-Cell Responses by gag mRNA-Electroporated Dendritic Cells from Treated and Untreated HIV Type 1-Infected Individuals

  2008cites this paper
• Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA

  2007cites this paper
• Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins.

  2007cites this paper
• Treating HIV-1 infection with dendritic cells.

  2007cites this paper
• Robust CD4+ and CD8+ T cell responses to SIV using mRNA‐transfected DC expressing autologous viral Ag

  2007cites this paper
• A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells

  2007cites this paper
• [mRNA-transfected dendritic cells: a promising strategy in immunotherapy].

  2007cites this paper
• Extensive HLA class I allele promiscuity among viral CTL epitopes

  2007cites this paper
• Divergence in CD8+ T cell epitopes of HIV -1 as an immune escape mechanism

  2007influential citation
• Les cellules dendritiques transfectées avec de l’ARN messager - Une approche prometteuse en immunothérapie

  2007cites this paper
• mRNA-based gene transfer as a tool for gene and cell therapy.

  2007cites this paper
• Modulation of cellular behavior by exogenous messenger RNA

  2006cites this paper
• of Epitopes and B Cell Responses to a Diverse Repertoire Cellular Trafficking Pathways and Prime T LAMP-1-HIV-1 Gag Chimeras Have Distinct Membrane Protein (LAMP) and Dendritic Cell-Lysosomal-Associated

  2006cites this paper
• DNA Encoding an HIV-1 Gag/Human Lysosome-Associated Membrane Protein-1 Chimera Elicits a Broad Cellular and Humoral Immune Response in Rhesus Macaques

  2006cites this paper
• IMMUNOTHÉRAPIE ANTITUMORALE PAR TRANSFERT DE L'ARN MESSAGER DE L'ANTIGÈNE MELANA/MART-1

  2006cites this paper
• Dendritic Cell-Lysosomal-Associated Membrane Protein (LAMP) and LAMP-1-HIV-1 Gag Chimeras Have Distinct Cellular Trafficking Pathways and Prime T and B Cell Responses to a Diverse Repertoire of Epitopes1

  2006cites this paper
• Synthetic Messenger RNA as a Tool for Gene Therapy

  2006cites this paper
• Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model

  2006cites this paper
• Cellular immune responses against CT 7 ( MAGE-C 1 ) and humoral responses against other cancer-testis antigens in multiple myeloma patients

  2005cites this paper